The DOI matches its Crossref record; 220 of the 220 references it cites were found in a registry or an index.
G protein-coupled receptors for energy metabolites as new therapeutic targets
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–220 of 220
GPR99, a new G protein-coupled receptor with homology to a new subgroup of nucleotide receptors
Wittenberger, T., Hellebrand, S., Munck, A., Kreienkamp, H., Schaller, H., & Hampe, W. (2002) · BMC Genomics · doi:10.1186/1471-2164-3-17 · Cited by 40
Discovery of Biaryl Anthranilides as Full Agonists for the High Affinity Niacin Receptor
Shen, H. C., Ding, F., Luell, S., Forrest, M. J., Carballo‐Jane, E., Wu, K. K., Wu, T.-J., Cheng, K., Wilsie, L. C., Krsmanovic, M. L., et al. (2007) · Journal of Medicinal Chemistry · doi:10.1021/jm700942d · Cited by 38
Is niacin ineffective? Or did AIM-HIGH miss its target?
Nicholls, S. J. (2012) · Cleveland Clinic Journal of Medicine · doi:10.3949/ccjm.79a.11166 · Cited by 38
Fluorinated pyrazole acids are agonists of the high affinity niacin receptor GPR109a
Skinner, P. J., Cherrier, M. C., Webb, P. J., Shin, Y., Gharbaoui, T., Lindstrom, A., Hong, V. T. M., Tamura, S. Y., Dang, H. T., Pride, C. C., et al. (2007) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2007.07.101 · Cited by 37
Ren, N., Kaplan, R. A., Hernandez, M., Cheng, K., Jin, L., Taggart, A. K. P., Zhu, A. Y., Gan, X., Wright, S. D., & Cai, T. (2009) · Journal of Lipid Research · doi:10.1194/jlr.m800625-jlr200 · Cited by 35
Potent tricyclic pyrazole tetrazole agonists of the nicotinic acid receptor (GPR109a)
Boatman, P. D., Schrader, T. O., Kasem, M., Johnson, B. R. G., Skinner, P. J., Jung, J., Xu, J., Cherrier, M. C., Webb, P. J., Semple, G., et al. (2010) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2010.03.062 · Cited by 34
Zhang, J., Chen, J., Li, Y., Cui, X., Zheng, X., Roberts, C. J., Lü, M., Elias, S. B., & Chopp, M. (2008) · Neurobiology of Disease · doi:10.1016/j.nbd.2008.07.011 · Cited by 30
Marklund, M., Landberg, R., Andersson, A., Åman, P., & Kamal‐Eldin, A. (2012) · British Journal Of Nutrition · doi:10.1017/s0007114512000621 · Cited by 29
Mahboubi, K., Witman-Jones, T., Adamus, J. E., Letsinger, J. T., Whitehouse, D. L., Moorman, A. R., Sawicki, D. R., Bergenhem, N. C. H., & Ross, S. A. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.12.022 · Cited by 28
Hirasawa, A., Itsubo, C., Sadakane, K., Hara, T., Shinagawa, S., Koga, H., Nose, H., Koshimizu, T., & Tsujimoto, G. (2007) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2007.10.142 · Cited by 28
3-Substituted 3-(4-aryloxyaryl)-propanoic acids as GPR40 agonists
Walsh, S. P., Severino, A., Zhou, C., He, J., Liang, G., Tan, C. P., Cao, J., Eiermann, G. J., Xu, L., Salituro, G., et al. (2011) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2011.03.114 · Cited by 26
Shen, H. C., Taggart, A. K. P., Wilsie, L. C., Waters, M. G., Hammond, M. L., Tata, J. R., & Colletti, S. L. (2008) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2008.08.039 · Cited by 24
GPR80/99, proposed to be the P2Y15 receptor activated by adenosine and AMP, is not a P2Y receptor
Qi, A., Harden, T. K., & Nicholas, R. A. (2004) · Purinergic Signalling · doi:10.1007/s11302-004-5069-0 · Cited by 23
Holzhäuser, E., Albrecht, C., Zhou, Q., Buttler, A., Preusch, M. R., Blessing, E., Katus, H. A., & Bea, F. (2011) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0b013e31820dc1db · Cited by 23
Shen, H. C., Szymonifka, M. J., Kharbanda, D., Deng, Q., Carballo‐Jane, E., Wu, K. K., Wu, T.-J., Cheng, K., Ren, N., Cai, T., et al. (2007) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2007.10.055 · Cited by 19
Pyrazole acids as niacin receptor agonists for the treatment of dyslipidemia
Schmidt, D. R., Smenton, A. L., Raghavan, S., Carballo‐Jane, E., Lubell, S., Ciecko, T., Holt, T. G., Wolff, M., Taggart, A. K. P., Wilsie, L. C., et al. (2009) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2009.06.054 · Cited by 13
Ding, F., Shen, H. C., Wilsie, L. C., Krsmanovic, M. L., Taggart, A. K. P., Ren, N., Cai, T., Wang, J., Tong, X., Holt, T. G., et al. (2010) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2010.04.013 · Cited by 12
Ingersoll, M. A., Potteaux, S., Álvarez, D., Hutchison, S. B., van Rooijen, N., & Randolph, G. J. (2011) · Immunobiology · doi:10.1016/j.imbio.2011.05.014 · Cited by 11
Bloomgarden, Z. T., & Handelsman, Y. (2011) · Journal of Diabetes · doi:10.1111/j.1753-0407.2011.00176.x · Cited by 8
Fibrate use in diabetes: New concepts
Bloomgarden, Z. T., & Drexler, A. (2010) · Journal of Diabetes · doi:10.1111/j.1753-0407.2010.00108.x · Cited by 6
Cited by
Singh, N., Gurav, A., Sivaprakasam, S., Brady, E., Padia, R., Shi, H., Thangaraju, M., Prasad, P. D., Manicassamy, S., Munn, D. H., et al. (2014) · Immunity · doi:10.1016/j.immuni.2013.12.007 · Cited by 2,368
Self-citationMetabolic Pathways in Immune Cell Activation and Quiescence
Pearce, E. L., & Pearce, E. J. (2013) · Immunity · doi:10.1016/j.immuni.2013.04.005 · Cited by 1,692
The Short Chain Fatty Acid Butyrate Imprints an Antimicrobial Program in Macrophages
Schulthess, J., Pandey, S., Capitani, M., Rue-Albrecht, K. C., Arnold, I., Franchini, F., Chomka, A., Ilott, N. E., Johnston, D. G. W., Pires, E., et al. (2019) · Immunity · doi:10.1016/j.immuni.2018.12.018 · Cited by 1,037
Free Fatty Acid Receptors in Health and Disease
Kimura, I., Ichimura, A., Ohue-Kitano, R., & Igarashi, M. (2020) · Physiological Reviews · doi:10.1152/physrev.00041.2018 · Cited by 1,018
Ketone bodies as signaling metabolites
Newman, J. C., & Verdin, E. (2014) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2013.09.002 · Cited by 966
Metadata
- Authors
- Blad, C. C., Tang, C., & Offermanns, S.
- Venue
- Nature Reviews Drug Discovery
- Published
- 2012-07-13
- Volume
- 11
- Issue
- 8
- Pages
- 603-619
- ISSN
- 1474-1776 (ISSN-L)
- 1474-1784
- OpenAlex
- W2068858277
- Cited by
- 273
- References
- 220
- FWCI
- 1.15
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.